주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

Alyson Kelvin

AK

Alyson Kelvin

University of Saskatchewan, Canada

Alyson Kelvin, PhD. Dr. Kelvin새 탭/창에서 열기 is a Scientist II at the Vaccine and Infectious Disease Organization (VIDO)새 탭/창에서 열기, Saskatoon, Canada. She completed her HBSc at Western University (London, Canada, 2003) and her PhD at Queen’s University (Belfast, Northern Ireland, 2007). Dr. Kelvin’s expertise is in the fields of virology and vaccinology specifically focusing on the development of broadly protective vaccines for emerging viruses. She has researched several high-profile emerging viruses including the 2009 H1N1 pandemic influenza virus, avian H5N1 influenza virus, Mpox virus, SARS-CoV, and SARS-CoV-2. She is a member of expert panels for the control of emerging viruses including the Public Health Agency of Canada’s (PHAC) Avian Influenza Expert Panel. Dr. Kelvin has been recognized with a CEPI-CIHR Leadership Award in Vaccine Research as well as the Canadian Society for Virology Early Career Award of Excellence.